Related Experiment Video

Updated: Aug 9, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population

B Lewis, A Chait, C M Oakley

    British Medical Journal
    |August 24, 1974
    PubMed

    Insights

    Serum lipoprotein abnormalities are common in ischaemic heart disease (I.H.D.), particularly in younger patients. Hyperlipoproteinaemia affects 55% of I.H.D. patients, with specific types linked to earlier disease onset.

    Area of Science:

    • Cardiology
    • Clinical Biochemistry
    • Lipidology

    Background:

    • Serum lipoproteins play a crucial role in lipid transport and cardiovascular health.
    • Abnormalities in lipoprotein profiles are recognized risk factors for ischaemic heart disease (I.H.D.).
    • Understanding these abnormalities in I.H.D. patients is vital for risk stratification and management.

    Purpose of the Study:

    • To quantitatively assess the frequency and nature of serum lipoprotein abnormalities in patients with I.H.D.
    • To compare lipoprotein profiles in I.H.D. patients with a healthy control population.
    • To investigate the relationship between specific hyperlipoproteinaemia types and patient age at I.H.D. onset.

    Main Methods:

    • Quantitative analysis of serum lipoproteins in 143 rigorously selected I.H.D. patients.
    • Comparison of findings with a control group exhibiting normal lipoprotein concentrations.
    • Classification of hyperlipoproteinaemia according to World Health Organization (W.H.O.) types.

    Main Results:

    • Hyperlipoproteinaemia was present in 55% of I.H.D. patients, notably in 11 of 15 patients under 40 years old.
    • Most frequent abnormalities included elevated triglycerides and cholesterol in very-low-density lipoprotein (VLDL), followed by elevated low-density lipoprotein (LDL) cholesterol.
    • Subnormal high-density lipoprotein (HDL) levels were observed in younger patients.
    • W.H.O. types IIa, IIb, III, IV, and V hyperlipoproteinaemia were over-represented in the I.H.D. cohort.
    • I.H.D. patients with W.H.O. types IIa, IIb, and IV abnormalities were significantly younger than those with normal lipoprotein levels.

    Conclusions:

    • Serum lipoprotein abnormalities are highly prevalent in patients with ischaemic heart disease.
    • Specific hyperlipoproteinaemia types (IIa, IIb, IV) are associated with a younger age of onset for I.H.D.
    • These findings underscore the importance of lipid profiling in the management and prevention strategies for I.H.D., especially in younger individuals.

    More Related Videos

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

    Published on: November 10, 2017

    Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation06:47

    Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

    Published on: January 28, 2021

    Related Concept Videos

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents

    Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
    Lipids: Dietary Sources and Requirements01:18

    Lipids: Dietary Sources and Requirements

    Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
    Cholesterol: Significance and Regulation01:29

    Cholesterol: Significance and Regulation

    Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
    Considering cholesterol and...
    Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

    Blood Studies for Cardiovascular System III: Serum Lipid Profile

    Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
    Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
    Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...